The phase I trial of IVA-337 in healthy volunteers.
Latest Information Update: 14 Aug 2015
At a glance
- Drugs Lanifibranor (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Inventiva Pharma
Most Recent Events
- 14 Aug 2015 New trial record